{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:27:13Z","timestamp":1781213233959,"version":"3.54.1"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.1001\/jamainternmed.2019.0677","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T09:15:30Z","timestamp":1561454130000},"page":"1084","source":"Crossref","is-referenced-by-count":522,"title":["Anticholinergic Drug Exposure and the Risk of Dementia"],"prefix":"10.1001","volume":"179","author":[{"given":"Carol A. C.","family":"Coupland","sequence":"first","affiliation":[{"name":"Division of Primary Care, University of Nottingham, Nottingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Hill","sequence":"additional","affiliation":[{"name":"Division of Primary Care, University of Nottingham, Nottingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Dening","sequence":"additional","affiliation":[{"name":"Division of Psychiatry and Applied Psychology, Institute of Mental Health, Nottingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Morriss","sequence":"additional","affiliation":[{"name":"Division of Psychiatry and Applied Psychology, Institute of Mental Health, Nottingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Moore","sequence":"additional","affiliation":[{"name":"University of Southampton Medical School, Primary Care and Population Sciences, Aldermoor Health Centre, Southampton, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hippisley-Cox","sequence":"additional","affiliation":[{"name":"Division of Primary Care, University of Nottingham, Nottingham, England"},{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10113","key":"ioi190025r1","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care.","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"ioi190025r2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","article-title":"2018 Alzheimer\u2019s disease facts and figures.","volume":"14","author":"Alzheimer\u2019s Association","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"8","key":"ioi190025r3","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/jgs.2011.59.issue-8","article-title":"Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study.","volume":"59","author":"Fox","year":"2011","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"ioi190025r4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/ageing\/afu096","article-title":"Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review.","volume":"43","author":"Fox","year":"2014","journal-title":"Age Ageing"},{"issue":"5","key":"ioi190025r6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1517\/14740338.2011.579899","article-title":"Drugs with anticholinergic properties: a current perspective on use and safety.","volume":"10","author":"Gerretsen","year":"2011","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"ioi190025r7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jalz.2012.02.005","article-title":"Long-term anticholinergic use and the aging brain.","volume":"9","author":"Cai","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"7539","key":"ioi190025r8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/bmj.38740.439664.DE","article-title":"Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study.","volume":"332","author":"Ancelin","year":"2006","journal-title":"BMJ"},{"issue":"14","key":"ioi190025r9","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/archinternmed.2009.229","article-title":"Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.","volume":"169","author":"Carri\u00e8re","year":"2009","journal-title":"Arch Intern Med"},{"issue":"2","key":"ioi190025r10","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1007\/s00406-010-0156-4","article-title":"Anticholinergic drug use and risk for dementia: target for dementia prevention.","volume":"260","author":"Jessen","year":"2010","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"ioi190025r11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study.","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"key":"ioi190025r12","doi-asserted-by":"publisher","first-page":"k1315","DOI":"10.1136\/bmj.k1315","article-title":"Anticholinergic drugs and risk of dementia: case-control study.","volume":"361","author":"Richardson","year":"2018","journal-title":"BMJ"},{"issue":"5","key":"ioi190025r13","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/ije\/dys147","article-title":"Case-control studies: basic concepts.","volume":"41","author":"Vandenbroucke","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"4","key":"ioi190025r14","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/jgs.2012.60.issue-4","article-title":"American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.","volume":"60","author":"American Geriatrics Society 2012 Beers Criteria Update Expert Panel","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"ioi190025r15","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults.","volume":"63","author":"By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"ioi190025r16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","article-title":"Impact of anticholinergics on the aging brain: a review and practical application.","volume":"4","author":"Boustani","year":"2008","journal-title":"Aging Health"},{"issue":"7","key":"ioi190025r17","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00228-013-1499-3","article-title":"Systematic review of anticholinergic risk scales in older adults.","volume":"69","author":"Dur\u00e1n","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"9770","key":"ioi190025r19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer\u2019s disease.","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"ioi190025r20","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1111\/obr.2011.12.issue-5","article-title":"Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies.","volume":"12","author":"Anstey","year":"2011","journal-title":"Obes Rev"},{"issue":"1","key":"ioi190025r21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12916-016-0549-y","article-title":"Predicting dementia risk in primary care: development and validation of the Dementia Risk Score using routinely collected data.","volume":"14","author":"Walters","year":"2016","journal-title":"BMC Med"},{"key":"ioi190025r22","first-page":"135","article-title":"Heart disease as a risk factor for dementia.","volume":"5","author":"Justin","year":"2013","journal-title":"Clin Epidemiol"},{"issue":"2","key":"ioi190025r23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.maturitas.2009.12.014","article-title":"Midlife predictors of Alzheimer\u2019s disease.","volume":"65","author":"Bendlin","year":"2010","journal-title":"Maturitas"},{"issue":"5","key":"ioi190025r24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1192\/bjp.bp.112.118307","article-title":"Late-life depression and risk of vascular dementia and Alzheimer\u2019s disease: systematic review and meta-analysis of community-based cohort studies.","volume":"202","author":"Diniz","year":"2013","journal-title":"Br J Psychiatry"},{"issue":"3","key":"ioi190025r25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1192\/bjp.bp.111.101931","article-title":"Affective disorders and risk of developing dementia: systematic review.","volume":"202","author":"da Silva","year":"2013","journal-title":"Br J Psychiatry"},{"issue":"4","key":"ioi190025r26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/aje\/kwm116","article-title":"Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies.","volume":"166","author":"Anstey","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"5","key":"ioi190025r27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/ageing\/afn095","article-title":"Alcohol, dementia and cognitive decline in the elderly: a systematic review.","volume":"37","author":"Peters","year":"2008","journal-title":"Age Ageing"},{"issue":"1","key":"ioi190025r28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jalz.2016.06.2360","article-title":"Systematic review of dementia prevalence and incidence in United States race\/ethnic populations.","volume":"13","author":"Mehta","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"5","key":"ioi190025r30","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/oxfordjournals.aje.a114174","article-title":"Estimating the population attributable risk for multiple risk factors using case-control data.","volume":"122","author":"Bruzzi","year":"1985","journal-title":"Am J Epidemiol"},{"key":"ioi190025r31","doi-asserted-by":"publisher","first-page":"k757","DOI":"10.1136\/bmj.k757","article-title":"Population attributable fraction.","volume":"360","author":"Mansournia","year":"2018","journal-title":"BMJ"},{"key":"ioi190025r32","doi-asserted-by":"publisher","first-page":"11398","DOI":"10.1038\/ncomms11398","article-title":"A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II.","volume":"7","author":"Matthews","year":"2016","journal-title":"Nat Commun"},{"issue":"5","key":"ioi190025r33","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s40520-016-0637-z","article-title":"Neuroinflammation, immune system and Alzheimer disease: searching for the missing link.","volume":"29","author":"Guerriero","year":"2017","journal-title":"Aging Clin Exp Res"},{"issue":"3","key":"ioi190025r34","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3233\/JAD-160488","article-title":"Inflammation, antiinflammatory agents, and Alzheimer\u2019s disease: the last 22 years.","volume":"54","author":"McGeer","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"S1","key":"ioi190025r35","first-page":"S142","article-title":"The 2012 update to the anticholinergic cognitive burden scale.","volume":"61","author":"Campbell","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"ioi190025r36","doi-asserted-by":"publisher","first-page":"e020738","DOI":"10.1136\/bmjopen-2017-020738","article-title":"Spatial distribution of clinical computer systems in primary care in England in 2016 and implications for primary care electronic medical record databases: a cross-sectional population study.","volume":"8","author":"Kontopantelis","year":"2018","journal-title":"BMJ Open"},{"issue":"2","key":"ioi190025r37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/147323000403200207","article-title":"The role of general practitioners in the diagnosis and treatment of Alzheimer\u2019s disease: a multinational survey.","volume":"32","author":"Wilkinson","year":"2004","journal-title":"J Int Med Res"},{"issue":"2","key":"ioi190025r38","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1017\/S0033291712001122","article-title":"Time to diagnosis in young-onset dementia as compared with late-onset dementia.","volume":"43","author":"van Vliet","year":"2013","journal-title":"Psychol Med"},{"issue":"5","key":"ioi190025r39","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/ana.v64:5","article-title":"Prodromal Alzheimer\u2019s disease: successive emergence of the clinical symptoms.","volume":"64","author":"Amieva","year":"2008","journal-title":"Ann Neurol"},{"issue":"7","key":"ioi190025r40","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1001\/jamapsychiatry.2017.0660","article-title":"Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study.","volume":"74","author":"Singh-Manoux","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"10130","key":"ioi190025r41","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(18)30570-1","article-title":"Prevention of dementia by targeting risk factors: authors\u2019 reply.","volume":"391","author":"Livingston","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"ioi190025r42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/2042098616659412","article-title":"Mirabegron in overactive bladder patients: efficacy review and update on drug safety.","volume":"7","author":"Warren","year":"2016","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"ioi190025r43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ajog.2016.01.156","article-title":"Nonantimuscarinic treatment for overactive bladder: a\u00a0systematic review.","volume":"215","author":"Olivera","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"ioi190025r18","volume-title":"Geriatric Dosage Handbook: Including Clinical Recommendations and Monitoring Guidelines","author":"Semla","year":"2010","edition":"15th ed"},{"key":"ioi190025r29","doi-asserted-by":"crossref","DOI":"10.1002\/9780470316696","volume-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"1987"},{"key":"ioi190025r5","unstructured":"National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers.https:\/\/www.nice.org.uk\/guidance\/ng97\/resources\/dementia-assessment-management-and-support-for-people-living-with-dementia-and-their-carers-pdf-1837760199109. Published June 20, 2018. Accessed May 16, 2018."}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/article-pdf\/179\/8\/1084\/17754718\/jamainternal_coupland_2019_oi_190025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T12:23:55Z","timestamp":1565007835000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2736353"}},"subtitle":["A Nested Case-Control Study"],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2019.0677","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,1]]}}}